|
1
|
Trousseau A: Plegmasia alba dolensLectures
on clinical medicine, delivered at the Hotel-Dieu, Paris. 5. The
New Sydenham Society; London: pp. 281–332. 1865
|
|
2
|
Varki A: Trousseau's syndrome: Multiple
definitions and multiple mechanisms. Blood. 110:1723–1729. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cestari DM, Weine DM, Panageas KS, Segal
AZ and DeAngelis LM: Stroke in patients with cancer: Incidence and
etiology. Neurology. 62:2025–2030. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Navi BB, Reiner AS, Kamel H, Iadecola C,
Okin PM, Elkind MSV, Panageas KS and DeAngelis LM: Risk of arterial
thromboembolism in patients with cancer. J Am Coll Cardiol.
70:926–938. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Navi BB, Reiner AS, Kamel H, Iadecola C,
Okin PM, Tagawa ST, Panageas KS and DeAngelis LM: Arterial
thromboembolic events preceding the diagnosis of cancer in older
persons. Blood. 133:781–789. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tachihara M, Nikaido T, Wang X, Sato Y,
Ishii T, Saito K, Sekine S, Tanino Y, Ishida T and Munakata M: Four
cases of trousseau's syndrome associated with lung adenocarcinoma.
Intern Med. 51:1099–1102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sato T, Tsujino I, Ikeda D, Ieko M and
Nishimura M: Trousseau's syndrome associated with tissue factor
produced by pulmonary adenocarcinoma. Thorax. 61:1009–1010. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masubuchi H, Maeno T, Uchida M, Kono S,
Suzuki M, Takemura M, Yamaguchi A, Yamaguchi K, Kanbe M and
Kitahara S: A case of trousseau syndrome caused by pulmonary
adenocarcinoma that was controlled for one year and 10 months with
thrombosis treatment using an EGFR tyrosine kinase inhibitor and
chemotherapy. Respir Med Case Rep. 15:101–105. 2015.PubMed/NCBI
|
|
9
|
Nonagase Y, Takeda M, Tanaka K, Hayashi H,
Iwasa T and Nakagawa K: Treatment of EGFR mutation-positive
non-small cell lung cancer complicated by Trousseau syndrome with
gefitinib followed by osimertinib: A case report. Oncotarget.
9:29532–29535. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Asakura H, Takahashi H, Uchiyama T, Eguchi
Y, Okamoto K, Kawasugi K, Madoiwa S and Wada H: Proposal for new
diagnostic criteria for DIC from the Japanese society on thrombosis
and hemostasis. Thromb J. 14:422016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang YY, Cordato D, Shen Q, Sheng AZ,
Hung WT and Chan DK: Risk factor, pattern, etiology and outcome in
ischemic stroke patients with cancer: A nested case-control study.
Cerebrovasc Dis. 23:181–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hattori A, Takamochi K, Kitamura Y,
Matsunaga T and Suzuki K, Oh S and Suzuki K: Risk factor analysis
of cerebral infarction and clinicopathological characteristics of
left upper pulmonary vein stump thrombus after lobectomy. Gen
Thorac Cardiovasc Surg. 67:247–253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho Y, Hida Y, Kaga K, Kato H, Iizuka M
and Kondo S: Brain metastases secondary to tumor emboli from
primary lung cancer during lobectomy. Ann Thorac Surg. 86:312–313.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsumoto N, Fukuda H, Handa A, Kawasaki
T, Kurosaki Y, Chin M and Yamagata S: Histological examination of
trousseau syndrome-related thrombus retrieved through acute
endovascular thrombectomy: Report of 2 Cases. J Stroke Cerebrovasc
Dis. 25:e227–e230. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishikawa M, Nakayama K, Ishibashi T, Sato
E, Nakamura K, Katagiri H and Kyo S: Case series of cerebral
infarction with trousseau's syndrome associated with malignant
gynecological tumors. Mol Clin Oncol. 5:138–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 world health organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wahrenbrock M, Borsig L, Le D, Varki N and
Varki A: Selectin-mucin interactions as a probable molecular
explanation for the association of trousseau syndrome with mucinous
adenocarcinomas. J Clin Invest. 112:853–862. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jovin TG, Boosupalli V, Zivkovic SA,
Wechsler LR and Gebel JM: High titers of CA-125 may be associated
with recurrent ischemic strokes in patients with cancer. Neurology.
64:1944–1945. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sawada M, Miyake S, Ohdama S, Matsubara O,
Masuda S, Yakumaru K and Yoshizawa Y: Expression of tissue factor
in non-small-cell lung cancers and its relationship to metastasis.
Br J Cancer. 79:472–477. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim S, Kim MY, Koh J, Go H, Lee DS, Jeon
YK and Chung DH: Programmed death-1 ligand 1 and 2 are highly
expressed in pleomorphic carcinomas of the lung: Comparison of
sarcomatous and carcinomatous areas. Eur J Cancer. 51:2698–2707.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ikematsu Y, Yoneshima Y, Ijichi K, Tanaka
K, Harada T, Oda Y, Nakanishi Y and Okamoto I: Marked response to
pembrolizumab in a patient with pulmonary pleomorphic carcinoma
highly positive for PD-L1. Lung Cancer. 112:230–231. 2017.
View Article : Google Scholar : PubMed/NCBI
|
